Paper41267682
Polypeptide encoded by the -1 PRF signal of SARS-CoV-2 controls multiple enzymatic activities of the viral NiRAN domain.
Hsu HT and 3 others. NAR Mol Med, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Polypeptide encoded by the -1 PRF signal of SARS-CoV-2 controls multiple enzymatic activities of the viral NiRAN domain. Papers, record 41267682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41267682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Polypeptide encoded by the -1 PRF signal of SARS-CoV-2 controls multiple enzymatic activities of the viral NiRAN domain.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28442579 | Avoidance of reporter assay distortions from fused dual reporters. | RNA | 2017 | https://conductscience.org/library/papers/28442579 | PubMed |
| 2 | 1404364 | Mutational analysis of the "slippery-sequence" component of a coronavirus ribosomal frameshifting signal. | J Mol Biol | 1992 | https://conductscience.org/library/papers/1404364 | PubMed |
| 3 | 18621088 | Frameshifting RNA pseudoknots: structure and mechanism. | Virus Res | 2009 | https://conductscience.org/library/papers/18621088 | PubMed |
| 4 | 33232691 | Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis. | Cell | 2021 | https://conductscience.org/library/papers/33232691 | PubMed |
| 5 | 21549154 | Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication. | Antiviral Res | 2011 | https://conductscience.org/library/papers/21549154 | PubMed |
| 6 | 12917450 | Mechanisms and enzymes involved in SARS coronavirus genome expression. | J Gen Virol | 2003 | https://conductscience.org/library/papers/12917450 | PubMed |
| 7 | 23334702 | Altering SARS coronavirus frameshift efficiency affects genomic and subgenomic RNA production. | Viruses | 2013 | https://conductscience.org/library/papers/23334702 | PubMed |
| 8 | 16055920 | An atypical RNA pseudoknot stimulator and an upstream attenuation signal for -1 ribosomal frameshifting of SARS coronavirus. | Nucleic Acids Res | 2005 | https://conductscience.org/library/papers/16055920 | PubMed |
| 9 | 34352100 | NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/34352100 | PubMed |
| 10 | 33472860 | Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/33472860 | PubMed |
| 11 | 36575184 | SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/36575184 | PubMed |
| 12 | 29976752 | Discovery and engineering of enhanced SUMO protease enzymes. | J Biol Chem | 2018 | https://conductscience.org/library/papers/29976752 | PubMed |
| 13 | 12927536 | Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. | J Mol Biol | 2003 | https://conductscience.org/library/papers/12927536 | PubMed |
| 14 | 33914787 | Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli. | PLoS One | 2021 | https://conductscience.org/library/papers/33914787 | PubMed |
| 15 | 34328734 | The SARS-CoV-2 Programmed -1 Ribosomal Frameshifting Element Crystal Structure Solved to 2.09 Å Using Chaperone-Assisted RNA Crystallography. | ACS Chem Biol | 2021 | https://conductscience.org/library/papers/34328734 | PubMed |
| 16 | 27436286 | Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27436286 | PubMed |
| 17 | 34029205 | Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome. | Science | 2021 | https://conductscience.org/library/papers/34029205 | PubMed |
| 18 | 35018474 | Coronaviral RNA-methyltransferases: function, structure and inhibition. | Nucleic Acids Res | 2022 | https://conductscience.org/library/papers/35018474 | PubMed |
| 19 | 33116300 | Coronavirus biology and replication: implications for SARS-CoV-2. | Nat Rev Microbiol | 2021 | https://conductscience.org/library/papers/33116300 | PubMed |
| 20 | 32438371 | Structure of replicating SARS-CoV-2 polymerase. | Nature | 2020 | https://conductscience.org/library/papers/32438371 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41267682
GET https://conductscience.org/api/papers/v1/41267682/references?page=2